
|Articles|November 1, 2002
Supplements and Featured Publications
- Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective
- Volume 8
- Issue 17 Suppl
Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using Coxibs
Author(s)James M. Scheiman, MD
Advertisement
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
2
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
3
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
4
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS
5





